Advertisement

Search Results

Advertisement



Your search for David M. O’Malley, MD, and Antonio Castaneda, MD matches 1 pages

Showing 1 - 1


gynecologic cancers

PARP Inhibitors in Maintenance Treatment for Advanced Ovarian Cancer

Based on multiple phase III prospective trials, there is evidence that both PARP inhibitors and antiangiogenic therapies such as bevacizumab provide benefit when utilized in a maintenance strategy in the first-line treatment of advanced epithelial ovarian cancer (GOG 218, ICON7, SOLO-1, PRIMA,...

Advertisement

Advertisement



Advertisement